CD8A and cancer: A recent study by Tan et al. demonstrated that HLA-A2-restricted NY-ESO-1157–165 transduced CD4+ T cells displayed higher binding affinity for the peptide than CD8+ T cells and were able to induce cancer cell cytotoxicity (118).